A
Ami Lifesciences
Manufacturer of Active Pharmaceutical Ingredients and intermediates
About Ami Lifesciences
Ami Lifesciences is a manufacturer and exporter of Active Pharmaceutical Ingredients (APIs) and advanced pharmaceutical intermediates. Founded in 2006 by Girish Chhotalal Chovatia and headquartered in Vadodara, India, the company serves leading pharmaceutical companies in over 60 countries. The founder, Girish Chovatia, holds an MBA and gained experience in the pharmaceutical industry before establishing his first venture, Ami Drugs & Specialty Chemicals Inc., in 1997, which was later renamed Ami Lifesciences in 2006.
The company specializes in custom synthesis and contract manufacturing, operating manufacturing facilities in Vadodara, Gujarat, and Raichur, Karnataka. Its products cater to various therapeutic areas, including cardiovascular, anti-diabetics, CNS, and respiratory. The business model is centered on being a reliable supplier of generic APIs and a contract development and manufacturing partner for a global client base that includes generic, big pharma, and innovator companies. Ami Lifesciences focuses on backward integration for key molecules to ensure cost competitiveness and supply chain security. The facilities comply with international standards such as EU-GMP and WHO-GMP.
In February 2020, the private equity firm Kedaara acquired a significant minority stake in the company. As of March 2024, the company reported revenue of ₹552 crore. The company has also appointed Amit Kaptain, a professional with over 20 years of experience in the API industry, as its CEO to build business strategy and global partnerships.
Source: Dealroom company dataNews
Open roles
Ami Lifesciences in the Vaghodia ecosystem
The Ami Lifesciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ami Lifesciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ami Lifesciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

